Organic Letters
Letter
that 3 is a thermally stable surrogate of Ab-Oxa for A.
baumannii.
(9) Zheng, T.; Nolan, E. M. J. Am. Chem. Soc. 2014, 136, 9677.
(
4
(
10) Chairatana, P.; Zheng, T.; Nolan, E. M. Chem. Sci. 2015, 6,
458.
11) Ghosh, M.; Miller, P. A.; Mollmann, U.; Claypool, W. D.;
̈
The current efforts to develop siderophore-based antibiotic
delivery systems have been primarily focused on targeting
drug-resistant Gram-negative pathogens including A. bauman-
Schroeder, V. A.; Wolter, W. R.; Suckow, M.; Yu, H.; Li, S.; Huang,
W.; Zajicek, J.; Miller, M. J. J. Med. Chem. 2017, 60, 4577.
11,12
nii. Recent reports by Miller and Nolan laboratories
are
(
12) Neumann, W.; Sassone-Corsi, M.; Raffatellu, M.; Nolan, E. M.
J. Am. Chem. Soc. 2018, 140, 5193.
̈
particularly worth paying attention to in that they have
successfully demonstrated the notable activity of cytoplasm-
targeting siderophore−antibiotic conjugates in Gram-negative
bacteria for the first time. While the antibiotic delivery
capability of anguibactin (3) and its deoxy derivative (4)
awaits experimental validation, it would be an intriguing
inquiry to be addressed whether they could serve as effective
vehicles to deliver antibiotic molecules inside drug-resistant A.
baumannii.
(
(14) Yamamoto, S.; Okujo, N.; Sakakibara, Y. Arch. Microbiol. 1994,
1
(
62, 249.
15) Proschak, A.; Lubuta, P.; Gru
Berardinis, V.; Bode, H. B. ChemBioChem 2013, 14, 633.
16) Penwell, W. F.; DeGrace, N.; Tentarelli, S.; Gauthier, L.;
̈
n, P.; Lohr, F.; Wilharm, G.; De
̈
(
Gilbert, C. M.; Arivett, B. A.; Miller, A. A.; Durand-Reville, T. F.;
Joubran, C.; Actis, L. A. ChemBioChem 2015, 16, 1896.
(17) Antunes, L. C. S.; Imperi, F.; Towner, K. J.; Visca, P. Res.
Microbiol. 2011, 162, 279.
ASSOCIATED CONTENT
Supporting Information
■
*
S
(18) Shapiro, J. A.; Wencewicz, T. A. ACS Infect. Dis. 2016, 2, 157.
(19) Shapiro, J. A.; Wencewicz, T. A. Metallomics 2017, 9, 463.
(20) Bohac, T. J.; Shapiro, J. A.; Wencewicz, T. A. ACS Infect. Dis.
2017, 3, 802.
Detailed experimental procedures for physicochemical
characterization, biological activity assay, energy calcu-
(21) Wuest, W. M.; Sattely, E. S.; Walsh, C. T. J. Am. Chem. Soc.
2009, 131, 5056.
(
22) Takeuchi, Y.; Ozaki, S.; Satoh, M.; Mimura, K.-I.; Hara, S.-I.;
Abe, H.; Nishioka, H.; Harayama, T. Chem. Pharm. Bull. 2010, 58,
552.
23) Actis, L. A.; Fish, W.; Crosa, J. H.; Kellerman, K.; Ellenberger,
1
(
AUTHOR INFORMATION
S. R.; Hauser, F. M.; Sanders-Loehr, J. J. Bacteriol. 1986, 167, 57.
(24) Dorsey, C. W. Microbiology 2004, 150, 3657.
■
*
(
(
25) Zamri, A.; Abdallah, M. A. Tetrahedron 2000, 56, 249.
26) Kim, J.; Lee, J. E.; Ree, H.; Kim, H. J. Bull. Korean Chem. Soc.
ORCID
2015, 36, 439.
27) Ree, H.; Kim, J.; Song, W. Y.; Lee, J. E.; Kim, H. J. Bull. Korean
Chem. Soc. 2015, 36, 1520.
28) Nelson, K. M.; Salomon, C. E.; Aldrich, C. C. J. Nat. Prod.
012, 75, 1037.
29) Jalal, M. A. F.; Hossain, M. B.; van der Helm, D.; Sanders-
(
Author Contributions
∥H.L. and Y.W.S. contributed equally.
(
2
(
Notes
Loehr, J.; Actis, L. A.; Crosa, J. H. J. Am. Chem. Soc. 1989, 111, 292.
(30) Oh, M. H.; Lee, J. C.; Kim, J.; Choi, C. H.; Han, K. Appl.
Environ. Microbiol. 2015, 81, 3357.
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
This study was supported by grants from the National
Research Foundation of Korea (NRF-2015R1D1A1A01-
■
0
56815, NRF2010-0020209) and the Korea Health Technol-
ogy R&D Project through the Korea Health Industry
Development Institute (KHIDI), funded by the Ministry of
Health & Welfare, Republic of Korea (Grant Number:
HI17C1657). K.K. is also thankful for the support from IBS-
R023-D1.
REFERENCES
■
(
1) Wong, D.; Nielsen, T. B.; Bonomo, R. A.; Pantapalangkoor, P.;
Luna, B.; Spellberg, B. Clin. Microbiol. Rev. 2017, 30, 409.
(
2) Dijkshoorn, L.; Nemec, A.; Seifert, H. Nat. Rev. Microbiol. 2007,
, 939.
3) Vila, J.; Marti, S.; Sanchez-Cespedes, J. J. Antimicrob. Chemother.
007, 59, 1210.
4) Zgurskaya, H. I.; Lop
015, 1, 512.
5) Song, W. Y.; Jeong, D.; Kim, J.; Lee, M. W.; Oh, M. H.; Kim, H.
J. Org. Lett. 2017, 19, 500.
6) Wilson, B. R.; Bogdan, A. R.; Miyazawa, M.; Hashimoto, K.;
Tsuji, Y. Trends Mol. Med. 2016, 22, 1077.
5
(
2
(
2
́
ez, C. A.; Gnanakaran, S. ACS Infect. Dis.
(
(
(
(
7) Schalk, I. J.; Mislin, G. L. A. J. Med. Chem. 2017, 60, 4573.
8) Wencewicz, T. A.; Miller, M. J. J. Med. Chem. 2013, 56, 4044.
D
Org. Lett. XXXX, XXX, XXX−XXX